Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Fukuda

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|May 14, 2005
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenemsShingo Mizunaga, Tomoko Kamiyama, Yoshiko Fukuda, et al.
Antiviral Research|October 9, 2002
Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in miceMasahiko Kurokawa, Minako Tsurita, Jacqueline Brown, et al.
Journal of Clinical Medicine|March 29, 2023
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma PatientsKazuyoshi Kitamura, Yoshiko Fukuda, Yuka Hasebe, et al.
Plos One|August 12, 2020
Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year resultsMio Matsubara, Yoichi Sakurada, Atsushi Sugiyama, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular DegenerationShuhei Hosoda, Yoichi Sakurada, Yoshiko Fukuda, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2013
Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infectionYoshiko Fukuda, Yuri Furuya, Yusuke Nozaki, et al.
Medicine|October 22, 2021
The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammationYumi Shigemoto, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month ResultWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Plos One|February 25, 2020
Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathyKikushima Wataru, Atsushi Sugiyama, Seigo Yoneyama, et al.
The Japanese Journal of Antibiotics|May 2, 2003
[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]Masako Maekawa, Yoshiko Fukuda, Yoko Sugiura, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|May 14, 2005
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenemsShingo Mizunaga, Tomoko Kamiyama, Yoshiko Fukuda, et al.
Antiviral Research|October 9, 2002
Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in miceMasahiko Kurokawa, Minako Tsurita, Jacqueline Brown, et al.
Journal of Clinical Medicine|March 29, 2023
Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma PatientsKazuyoshi Kitamura, Yoshiko Fukuda, Yuka Hasebe, et al.
Plos One|August 12, 2020
Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year resultsMio Matsubara, Yoichi Sakurada, Atsushi Sugiyama, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular DegenerationShuhei Hosoda, Yoichi Sakurada, Yoshiko Fukuda, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2013
Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infectionYoshiko Fukuda, Yuri Furuya, Yusuke Nozaki, et al.
Medicine|October 22, 2021
The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammationYumi Shigemoto, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month ResultWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Plos One|February 25, 2020
Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathyKikushima Wataru, Atsushi Sugiyama, Seigo Yoneyama, et al.
The Japanese Journal of Antibiotics|May 2, 2003
[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]Masako Maekawa, Yoshiko Fukuda, Yoko Sugiura, et al.
Pageof 7